poisar

Stocks · News reference

OMRON Raises FY2026 GAAP EPS Guidance from $0.89 to $1.29 vs $1.22 Est; Raises FY2026 Sales Guidance from $5.228B to $5.522B

Aug 5, 2026, 8:46 AMBenzinga Newsdesk

OMRON (OTC:OMRNY) raises FY2026 GAAP EPS guidance from $0.89 to $1.29 vs $1.22 analyst estimate. Raises FY2026 sales outlook from $5.228 billion to $5.522 billion

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

OMRNY
Source
benzinga
Observed
Aug 5, 2026, 8:46 AM
Checked
Aug 5, 2026, 8:46 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  2. Jul 17, 2026, 12:53 PMSns Insider

    Muscle Stimulator Market Size to Reach USD 1,156.54 Million by 2035 | SNS Insider

    The global muscle stimulator market is valued at $812.01 million in 2025 and is projected to reach $1,156.54 million by 2035, growing at a CAGR of 3.6%. Growth is driven by increasing adoption of neuromuscular electrical stimulation devices for pain management, rehabilitation, and sports medicine. TENS technology dominates with 67.4% market share, while portable devices account for 46.88% of the market. North America leads with 41.9% revenue share, while Asia Pacific registers the fastest growth.

    Read original at globenewswire-inc
    OMRNY